A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
National Cancer Institute (NCI)
Incyte Corporation
Pfizer
Incyclix Bio
Terremoto Biosciences Inc.
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
University of Oklahoma